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Introduction
Confirmation of diagnosis of TBM is often
difficult. Bacteriological confirmation of the
disease is by demonstration of acid fast bacilli in
C S F  b y  m i c r o s c o p y  a n d  i s o l a t i o n  o f
M.tuberculosis in culture. Since culture takes a
long time and only less than 5% of TBM cases
are positive by smear examination, there is an
urgent need for simple, specific and rapid tests
for the diagnosis of TBM.
Several  indirect tests,  such as lactate
dehydrogenase level1, lactate concentration2,
bromide partition test3 and many direct tests such
as detection of mycobacterial antigen4,5 a n d
presence of tuberculostearic acid6 were suggested
for the early diagnosis of TBM. None of these
tests have been accepted as routine procedure in
clinical microbiology laboratories7. T.M. Daniel8
has reviewed the value of various direct and
indirect tests for the rapid diagnosis of TBM.
ADA catalyses the deamination of adenosine
into inosine and ammonia. It is secreted by
T-lymphocytes andmacrophages during
infections. So, there has been interest in ADA as
a marker of chronic inflammatory conditions such
as tuberculous pleural effusions9, tuberculous
peritonitis10 and TBM7,11 .
Lysozyme, secreted by the monocytic cell
series, was reported by us12 as useful for the
differential diagnosis of meningitis. Hence, the
objectives of the present study were to assess the
usefulness of ADA test and to compare it with
LYSA test in the diagnosis of TBM in children.
Material and Methods
Patients : The patients included in this study
were children aged below 12 years, divided into 4
groups:
Group 1. (Confirmed TBM) : The CSF from all
the 26 patients in this group was culture positive
for M.tubercu1osis
Group 2. (Clinical TBM) : The 61 patients in this
group were clinically diagnosed as suffering from
TBM but their CSF was negative by smear and
culture. The diagnosis in them was based on
clinical features, history of contact, Mantoux test,
biochemical findings of CSF and presence of
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evidence for tuberculosis elsewhere in the body.
Group 3. (Non-TBM) : The 10 patients in this
group were clinically diagnosed as suffering from
pyogenic meningitis. S.pyogenes was isolated from
one and H.influenzae from the other patient and
the CSF specimens from the remaining 8 patients
were reported as culture sterile.
Group 4. (Control) : The CSF from patients
with febrile fits(8), epilepsy (1), neuromuscular
disorder (1), seizure disorder (1), cerebrovascular
accident (3) and conditions such as hydrocele (2),
anal fissure (l), where spinal anaesthesia was
given constituted the control group. All the 17
CSF samples were biochemically normal and
culture negative for AFB and non-AFB.
ADA assay : The ADA assay was performed as
described by Giusti et al13 . The CSF specimens
were kept in the deep freezer (-20° C) for 7 to 10
days before the assay was done. The assay was set
up on a routine basis and the details of the
specimens were not known. On each day of the
assay a pooled CSF sample was included as a
control. The ADA content was expressed in U/I
of CSF. Coefficient of variation was found to be
20% for a pooled CSF sample with a mean ADA
level of 10.12 U/I in 9 consecutive assays.
Lysozyme assay : The lysozyme content was
estimated by the turbidity measurement as
described by Jain at al14 . A pooled CSF sample
was included to monitor the variation in the
assay. The lysozyme content was expressed in
mcg/ml of CSF. The coefficient of variation for
the pooled CSF sample with a mean LYSA level
of 1.43 mcg/ml was 15% in 7 consecutive assays.
AFB culture : All the CSF specimens were
subjected to smear examination by fluorescence
microscopy and processed for culture using
multiple media as practised in this Centre15.
Non-AFB culture : The CSF specimens from
the control and Non-TBM groups were examined
for Non-AFB by the conventional procedures.
Statistical method : Univariate statistical
analysis was carried out for the groups,
separately. The comparisons of the means of
various groups of meningitis were made using
Kruskal-Wallis non-parametric one-way ANOVA
test. The association between ADA and LYSA
levels was determined using Pearson correlation
coefficient and their significance using t-test.
Unless otherwise stated, a statistical significance
indicates P value less than 0.05.
Results
The frequency distribution, mean, standard
deviation and range of ADA values in different
groups are given in Table 1. The mean level of
ADA in confirmed TBM was 11.6 U/l and was
ignificantly higher than the other three groups
(P <0.000l). In the confirmed TBM group, 25
(96%) of 26 had ADA values more than 4 U/l.
All the 17 in the control group and 7 of 10 in
Non-TBM group had values less than 4 U/l. So,
an ADA level of 4 U/l and above was considered      
diagnostic of TBM. With this criterion, the
sensitivity and specificity of the test were 96%
and 82% respectively.
The frequency distribution, mean, standard
deviation and range of LYSA levels in different
groups are given in Table 2. The mean level of
LYSA in confirmed TBM was 6.3 mcg/ml and
was significantly higher than the other three
groups (P < 0.0001). In confirmed TBM, 23
(88%) out of 26 had LYSA values higher than 2
mcg/ml. All the 17 in the control group and 9 out
of 10 in the Non-TBM group had values less than
2 mcg/ml. So, a LYSA value of 2 mcg/ml and
above was considered diagnostic of TBM. With
this criterion, the sensitivity and specificity of the
test were found to be 85% and 95% respectively.
The results of ADA and LYSA tests in
bacteriologically positive and negative TBM  
groups are presented in Table 3. In
bacteriologically positive TBM, 25 (96%) out of     
26 were positive by ADA test whereas 23 (88%)_
were positive by LYSA test. By applying either of
the two tests a probable diagnosis of TBM could
be made in 49% of 61 cases without
bacteriological confirmation.
The correlation coefficient between the ADA
and LYSA levels in the confirmed TBM was
found to be statistically significant (r = 0.59;
P < 0.01)
Discussion
In the present study, ADA levels ranged from
2.5 to 25.5 U/l in confirmed TBM. In pediatric
populations, Malan et al16 and Coovadia et al7
reported a range of 4.7 to 32.7 U/l and 7.1 to 32.5
U/l respectively. A range of 9.1 to 22.7 U/l was
reported by Ribera et al” in adults. These results
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Table 1. Distribution of ADA levels.
Groups
ADA Confirmed Clinical Non-TBM Control
(U/l) TBM TBM
0- 0 25 3 17
2- 1 10 4
4- 6 15
8- 10 8 3
12- 9 3
Total 26 61 10 17
Mean 11.6 4.5 4.4 0.8
SD 6.2 4.3 4.0 0.5
Range 2.5-25.4 0.1-20 1.0-10.9 0.0-1.6
Table 2. Distribution of LYSA levels
LYSA Confirmed Clinical Non-TBM Control
(mcg/ml) TBM TBM
0- 3 38 5 15
l- 1 4 4 2
2- 2 6
4- 11 9
8- 9 4 1
Total 26 61 10 17
Mean 6.3 2.1 2.2 0.5
\
SD 3.4 2.8 3.9 0.6
Range 0.0-10.8 0.0-10.5 0.3-13.1 0.0-1.6
TaBLE 3. Results of ADA and LYSA tests in bacteriologi-
tally positive and negative TBM
Bact. neg.TBM Bact. pos.TBM
Test status Number  % Number %
Both positive 15 24.5 22 85
ADA positive
LYSA negative 11 18.0 3 11
LYSA positive
ADA negative 4 6.5 - -
Both negative 31 51.0 1 4
Total 61 100 26 100
show that ADA secretion by T-lymphocytes in
response to mycobacterial infection is similar in
different ethnic groups.
In this investigation, an ADA value of 4 U/l
and above was considered consistent with
tuberculous pathology. Mann et all7 used the
same criterion for the differential diagnosis of
meningitis. Malan et alI6 reported a value of 6
U/l as the cut off point for classification;
Coovadia et al7 had a cut-off point of 10 U/l for
differentiation while in adults Ribera et al11
considered a value of 9 U/l as the significant
level. The variations in the diagnostic cut-off
levels in these reports could be due to the type of
controls investigated.
In this study, a LYSA level of 2 mcg/ml was
considered as diagnostic while Matti Klockars et
alI8 used 1.5 mcg/ml as the cut off point.
In this study, 3 of 10 Non-TBM patients had
ADA values more than 4 U/l . similarly, Malan et
all6 reported that 13 (31%) of 42 patients with
bacterial meningitis had values higher than 9 U/l.
Coovadia et al7 observed that 14 of 16 Non-TBM
patients had ADA levels more than 10 U/I. It is,
therefore, evident that the CSF from patients
with pyogenic meningitis had also elevated ADA
levels.  This aspect should be taken into
consideration while interpreting ADA test
results. Ribera et al11 h d reported that only 2
(1%) out of 213 cases of Non-TBM had ADA
values higher than 9 U/l without any explanation.
It is, therefore,imperative that pyogenic
meningitis is ruled out by an initial screening,
before elevated levels of ADA and LYSA levels
are considered for the diagnosis of TBM.
Considering either of the two test definitions,
49% of 61 clinically suspected and
bacteriologically negative cases of TBM in the
current study had additional supportive evidence
in favour of their diagnosis.
The agreement between ADA and LYSA tests
in the classification of different groups of
meningitis was found to be 97%. The difference
between the two tests is not statistically
significant (Sign test; P > 0.2). These results
suggest that either LYSA or ADA could be
applied as an additional test for the diagnosis of
TBM.
Considering the practical aspects of the two
tests, LYSA test requires only culture suspension
of Micrococcus lysodeikticus which can be grown
and maintained on nutrient agar. On the other
hand, ADA test needs reagents which are
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expensive and have a short shelf life i.e.. around
30 days. Also,  the assay involves the
measurement of ammonia and utmost care
should be taken to avoid contamination with tap
water. Since LYSA assay is very simple and
inexpensive, compared to ADA, it can be
performed in laboratories with limited financial
support. Thus, it may be observed that LYSA
test is simple to perform and as sensitive and
specific as the ADA test in the diagnosis of
TBM.
In conclusion , ADA level of 4 U/l and above
and LYSA level of 2 mcg/l and above in CSF
could provide additional supportive evidence
for the diagnosis of TBM in clinically
suspected and bacteriologically negative cases.
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